How Much Does Provigil (Modafinil) Cost in New Mexico in 2026?

Brand vs. Generic Modafinil Pricing in New Mexico

The single biggest factor in what you pay is whether you fill a brand-name or generic prescription. Brand Provigil, marketed by Cephalon (now a Teva subsidiary), carries a wholesale acquisition cost near $850 for a 30-day supply of 200 mg tablets. Generic modafinil, available from manufacturers including Teva, Mylan, and Aurobindo, averages around $80 per month at New Mexico retail pharmacies in 2026.

That roughly 10:1 price gap exists because modafinil lost patent exclusivity in 2012. The FDA's Orange Book lists multiple approved ANDA holders for modafinil tablets in 100 mg and 200 mg strengths. Competition among generic manufacturers has steadily driven cash prices down. A decade ago, generic modafinil still ran $200 to $300 per month. Today, pharmacy discount platforms frequently list 30 tablets of generic modafinil 200 mg between $15 and $45 at select New Mexico locations, including chains like Walmart, Costco, and Smith's.

Prices vary by pharmacy. Independent pharmacies in rural parts of New Mexico (Clovis, Gallup, Las Cruces) may quote higher cash prices than Albuquerque or Santa Fe locations because of lower prescription volume and different wholesale contracts. Calling ahead or checking a discount aggregator before filling can save $30 to $50 on a single fill.

New Mexico Medicaid and Modafinil Coverage

New Mexico Medicaid, administered through managed care organizations (MCOs) including Blue Cross Blue Shield of New Mexico, Presbyterian Health Plan, and Western Sky Community Care, does not cover Provigil or generic modafinil on its preferred drug list as of 2026. This means beneficiaries cannot obtain modafinil through their Medicaid pharmacy benefit without a prior authorization, and even with PA, approvals are rare because the drug is excluded from the formulary rather than simply non-preferred.

Why the exclusion? State Medicaid programs have broad discretion over which Schedule IV controlled substances they include. Modafinil's primary FDA-approved indications (narcolepsy, shift work disorder, and residual excessive sleepiness in obstructive sleep apnea) overlap with lower-cost alternatives that Medicaid does cover, and some states view the off-label cognitive-enhancement demand as a cost risk. The FDA label for Provigil specifies that the drug is not a replacement for sleep, and Medicaid formulary committees often weigh that language when setting coverage policy.

For New Mexico Medicaid enrollees diagnosed with narcolepsy, options include requesting an exception through the MCO's prior authorization process. Documentation typically requires a polysomnography report and a multiple sleep latency test (MSLT) confirming a diagnosis per American Academy of Sleep Medicine (AASM) guidelines. Even with this documentation, approval is not guaranteed. Patients denied coverage can file an appeal through the New Mexico Human Services Department or explore manufacturer assistance programs.

Insurance Coverage Beyond Medicaid

Commercial insurance plans sold on the New Mexico Health Insurance Exchange (beWellnm) and employer-sponsored plans handle modafinil differently than Medicaid. Most commercial formularies place generic modafinil on Tier 2 (preferred generic) or Tier 3 (non-preferred generic), with copays ranging from $10 to $50 per fill. Brand Provigil, when covered at all, sits on Tier 4 (specialty) or is excluded entirely with a mandatory generic substitution policy.

Blue Cross Blue Shield of New Mexico, Presbyterian, and Molina Healthcare each publish annual formularies. As a general pattern across commercial plans nationally, generic modafinil coverage requires a prior authorization confirming one of the three FDA-approved diagnoses. Off-label prescriptions for cognitive enhancement or fatigue related to depression typically do not meet PA criteria.

Self-insured employer plans (common among New Mexico's larger employers like Sandia National Laboratories, Presbyterian Healthcare Services, and the University of New Mexico) set their own formulary rules. Some self-insured plans cover modafinil with minimal restrictions. Checking with your plan's pharmacy benefit manager (PBM) before assuming coverage is not available can prevent unnecessary out-of-pocket spending.

Tricare, which covers a significant population near Kirtland Air Force Base and White Sands Missile Range, includes generic modafinil on its formulary with a $14 copay at military pharmacies and $34 at retail network pharmacies. Active-duty service members can obtain it at no cost through military treatment facility pharmacies.

The Role of 503A Compounding Pharmacies in New Mexico

Compounded modafinil is legal in New Mexico through 503A-licensed compounding pharmacies. Under FDA guidance on 503A compounding, a 503A pharmacy may compound a drug for an individual patient based on a valid prescription from a licensed prescriber, provided the compounded product is not essentially a copy of a commercially available drug.

That last clause matters. Because generic modafinil tablets are commercially available in standard 100 mg and 200 mg strengths, a 503A pharmacy generally cannot compound an identical tablet. Compounding is permissible when a patient needs a non-standard dosage form (liquid suspension for patients who cannot swallow tablets), an allergen-free formulation (dye-free, gluten-free), or a dose not commercially available (such as 50 mg or 150 mg). Several New Mexico compounding pharmacies, including operations in Albuquerque and Las Cruces, offer these formulations.

Pricing for compounded modafinil varies widely. Some compounding pharmacies price formulations competitively with generic tablets. Others charge a premium for custom preparations. Because compounded medications are not covered by most insurance plans or PBMs, patients pay cash. Requesting a price quote from at least two compounding pharmacies is a reasonable step before committing.

The New Mexico Board of Pharmacy oversees 503A facilities operating within the state. Out-of-state 503B outsourcing facilities may also ship compounded modafinil into New Mexico, subject to both federal 503B regulations and New Mexico's importation rules.

Telehealth Prescribing of Modafinil in New Mexico

New Mexico permits telehealth prescribing of modafinil. The state's Telehealth Act (NMSA 1978 §24-25-1 et seq.) allows licensed prescribers to evaluate patients and issue prescriptions via synchronous audio-video visits. Because modafinil is a Schedule IV controlled substance under the DEA's classification, federal rules require an initial audio-video encounter (not audio-only) before a controlled substance prescription can be issued.

The DEA's 2023 telemedicine prescribing rule extended pandemic-era flexibilities for Schedule III through V substances through 2025, and subsequent rulemaking has continued to permit telehealth initiation of Schedule IV prescriptions with a video evaluation. New Mexico has not imposed additional state-level restrictions beyond the federal baseline.

Several telehealth platforms operating in New Mexico prescribe modafinil for narcolepsy and shift work disorder. Consultation fees typically range from $99 to $199 for an initial evaluation. Patients should confirm that the prescriber holds an active New Mexico medical license and a valid DEA registration before the visit. The prescription can then be sent electronically to any New Mexico pharmacy, including mail-order and compounding pharmacies.

Discount Programs and Savings Strategies

Multiple pathways exist for reducing modafinil costs in New Mexico. The most effective approach depends on whether you have insurance.

Pharmacy discount cards and aggregators. GoodRx, RxSaver, and SingleCare negotiate rates with PBMs that can bring generic modafinil below $20 for 30 tablets at high-volume pharmacies. These prices fluctuate weekly. Costco Pharmacy in Albuquerque consistently ranks among the lowest-cost options in the state, and Costco does not require a membership to use its pharmacy.

Manufacturer savings programs. Teva, which owns the Provigil brand, has periodically offered copay cards that reduce out-of-pocket costs for commercially insured patients. These cards typically do not apply to government-funded insurance (Medicaid, Medicare Part D, Tricare). Savings card terms change annually, so verifying current availability on the manufacturer's website before relying on one is worth the two minutes it takes.

Pill splitting. Generic modafinil 200 mg tablets are scored. With prescriber approval, filling a 200 mg prescription and splitting tablets to achieve a 100 mg dose can halve the per-dose cost. The US Modafinil in Narcolepsy Multicenter Study Group trial published in Annals of Neurology demonstrated efficacy at both 200 mg and 400 mg daily doses, and clinical practice often starts patients at 100 mg to assess response. Splitting is a practical strategy when 100 mg is the target dose.

Mail-order pharmacies. Filling a 90-day supply through a mail-order pharmacy (Express Scripts, CVS Caremark, or Amazon Pharmacy) often reduces per-tablet cost by 15% to 30% compared to 30-day retail fills. New Mexico does not restrict mail-order delivery of Schedule IV substances when shipped by a licensed pharmacy.

Patient assistance programs. NeedyMeds and RxAssist maintain databases of assistance programs. Patients below 200% of the federal poverty level may qualify for free or reduced-cost modafinil through manufacturer or nonprofit programs. In New Mexico, where the 2026 median household income is approximately $58,000, a meaningful portion of the population falls within eligibility thresholds.

Clinical Context: What Modafinil Does and Who It Helps

Modafinil promotes wakefulness through mechanisms that are not fully characterized but appear to involve dopamine reuptake inhibition and orexin pathway activation. The FDA approved Provigil in 1998 based on key trials including the US Modafinil in Narcolepsy Multicenter Study, which enrolled 283 patients with narcolepsy across nine centers. Patients receiving modafinil 200 mg or 400 mg daily showed statistically significant improvements in the Maintenance of Wakefulness Test (MWT) compared to placebo (P<0.001 for both doses vs. placebo).

A Cochrane systematic review of drugs for narcolepsy confirmed moderate-certainty evidence supporting modafinil's efficacy for reducing excessive daytime sleepiness. The review noted that adverse effects (headache, nausea, anxiety) were generally mild and self-limiting at standard doses.

For shift work disorder, a randomized controlled trial published in the New England Journal of Medicine (N=209) found that modafinil 200 mg taken before night shifts reduced the frequency of lapses of attention on a psychomotor vigilance task and modestly improved Clinical Global Impression scores. The effect size was moderate. Modafinil does not eliminate the health risks of chronic shift work.

Off-label prescribing for cognitive enhancement, ADHD adjunct therapy, and fatigue associated with multiple sclerosis or depression is common but not FDA-approved. New Mexico prescribers may write off-label prescriptions at their clinical judgment, but insurance coverage for off-label use is typically denied.

How New Mexico Compares to Neighboring States

Generic modafinil cash prices in New Mexico ($80 average) fall in line with neighboring Arizona ($75 to $85) and Colorado ($70 to $80). Texas, with higher pharmacy density and competition, averages slightly lower at $65 to $75. The Medicaid exclusion in New Mexico mirrors the approach taken by Arizona's AHCCCS program, while Colorado Medicaid covers generic modafinil with prior authorization for narcolepsy only.

Patients living near the Texas or Colorado borders may find lower prices by filling prescriptions across state lines. Both states permit out-of-state prescriptions for Schedule IV substances when presented at a licensed in-state pharmacy. A patient in Las Cruces, for example, could fill at an El Paso pharmacy if the price difference justifies the drive.